SCHEDULE OF CONDENSED INCOME STATEMENT (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues, net	$ 23,323,000	$ 18,134,000	$ 45,443,000	$ 33,577,000
Loss from operations	1,690,000	4,169,000	3,791,000	7,086,000
Net loss	$ (6,239,000)	$ (2,478,000)	(8,677,000)	(2,261,000)
Melt Pharmaceuticals, Inc. [Member]
Revenues, net
Loss from operations			(6,518,000)	(2,177,000)
Net loss			$ (6,518,000)	$ (2,177,000)